Early Diagnosis of Pancreatic Cancer Using NGAL
Author Information
Author(s): Moniaux N, Chakraborty S, Yalniz M, Gonzalez J, Shostrom V K, Standop J, Lele S M, Ouellette M, Pour P M, Sasson A R, Brand R E, Hollingsworth M A, Jain M, Batra S K
Primary Institution: University of Nebraska Medical Center
Hypothesis
NGAL plays an important role in the early stages of pancreatic cancer pathogenesis and its detection could potentially be useful in the diagnosis of pancreatic cancer.
Conclusion
NGAL is highly expressed in early dysplastic lesions in the pancreas, suggesting a possible role as an early diagnostic marker for pancreatic cancer.
Supporting Evidence
- NGAL expression was detected as early as the PanIN-1 stage.
- Serum NGAL levels were above the cutoff for healthy individuals in 94% of pancreatic cancer samples.
- The average composite score for adenocarcinoma was significantly higher than that for the normal pancreas or pancreatitis.
Takeaway
Scientists found a protein called NGAL that can help spot early signs of pancreatic cancer, which is really hard to catch early.
Methodology
The study examined NGAL expression in pancreatic tissues and cell lines using immunohistochemistry and RT-PCR, and analyzed serum NGAL levels using ELISA.
Limitations
The study did not observe any PanIN lesions in the sections of normal pancreas, possibly due to the small number of normal tissues examined.
Participant Demographics
The study included pancreatic tissue samples from healthy donors, patients with acute and chronic pancreatitis, and patients with pancreatic ductal adenocarcinoma.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website